PRESS RELEASE

November 25, 2015

[Post by:  J.L. Adams, the DeSean Jackson Foundation]

Gayle and DeSean Jackson, of the DeSean Jackson, held a press conference at the Washington Redskins’ facility to make a public statement about National Pancreatic Cancer Awareness Month; and, to make a $10,000 donation to John Hopkins University for research in memory of DeSean’s father, William Jackson, who died from Pancreatic Cancer in 2009 when DeSean was a rookie with the Philadelphia Eagles.

Gayle Jackson, President and DeSean Jackson, CEO, DeSean Jackson Foundation

Gayle Jackson, President and DeSean Jackson, CEO, DeSean Jackson Foundation

Gayle Jackson,  Dr. Ralph Hruban, M.D., DeSean Jackson

Gayle Jackson, Dr. Ralph Hruban, M.D., DeSean Jackson

John Hopkins University, Pancreatic Cancer Research Team

John Hopkins University, Pancreatic Cancer Research Team

The Multidisciplinary Pancreatic Cancer Team at Johns Hopkins is committed to providing the highest level of care to individuals suffering from pancreatic cancer and related conditions. The team is comprised of many of the world’s leading experts in pancreatic cancer. Surgeons at Johns Hopkins have performed over 3,000 Whipple resections, more than any other institution in the world.

History of The Sol Goldman Pancreatic Cancer ReSearch Center

The Sol Goldman Charitable Trust, a New York-based philanthropy endowed The Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins in 2005. This center supports a multi-disciplinary team of physicians and scientists. The gift of $10 million to endow the center, one of the largest ever to a pathology department, represents the remarkable vision of Jane Goldman, a New York real estate developer. After losing her mother, Lillian Goldman, to pancreatic cancer in 2002, Jane decided to take action against the disease that took her mother’s life. With the help of her husband, Dr. Benjamin Lewis, the family approached the team at Johns Hopkins with the goal of endowing a pancreatic cancer research center that would not only combat this terrible disease, but would also honor the legacy of Jane’s parents, Sol and Lillian Goldman.
##
The newly endowed center is named The Sol Goldman Pancreatic Cancer Research Center. Sol Goldman started the family real estate business at the age of 17. He and Lillian were married when Lillian was 18, and together they built extensive real estate holdings including, briefly, the Belvedere Hotel here in Baltimore. The Sol Goldman Charitable Trust is an independent foundation established in 1988 in New York City to support the arts, education, the environment, health organizations, human services, and Jewish agencies.
##
One of the remarkable aspects of this gift to Johns Hopkins is that the Goldman family does not have historic ties to Hopkins. Instead, the family had the vision and selflessness to go beyond their native New York to seek out and support the leading pancreatic cancer research group. The group’s team approach, past record of success, and desire to pursue novel ideas all attracted the Goldman’s to Hopkins.
##
The Center is directed by Dr. Ralph Hruban, with leadership representation from the departments of Surgery, Oncology, Radiation Oncology and Radiology. Institutional leadership and the Goldman family will help guide the Center.
##
In addition to Dr. Hruban, this multi-disciplinary center includes Drs. Nita Ahuja, Syed Ali, John Cameron, Marcia Canto, Michael Choti, Ross Donehower, Frederick Eckhauser, Jim Eshleman, Eliot Fishman, Michael Goggins, Joseph Herman,Chris Iacobuzio-Donahue, Liz Jaffee, Scott Kern, Alison Klein, Dan Laheru, Steven Leach, Anirban Maitra, Martin Makary, Timothy Pawlik, Marty Pomper, Chris Wolfgang, Matt Weiss and Lei Zheng. The group also has a number of exciting collaborations with additional investigators in the Institute for Genetic Medicine and the School of Nursing at Hopkins. The secret to the success of the center has been the interaction of individuals with diverse backgrounds collaborating in a multi-disciplinary way using unique skills to tackle the same enemy.
##
With the recent severe decline in NIH funding, gifts such as this are essential to our efforts to fight pancreatic cancer. Thanks to this extremely generous family, we can be assured that the war against pancreatic cancer will continue for years to come. Income from the endowment will be used to support novel pancreatic cancer research. Each year a request for applications will be distributed to all scientists throughout Hopkins, soliciting their interest in applying for research funding in the field of pancreas cancer. These grants will be reviewed by a scientific advisory board which will award funding to projects that hold the most promise.